Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-22

Clinical Trial Update: Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating gemcitabine and oxaliplatin chemotherapy with optional floxuridine/dexamethasone pump in patients with unresectable intrahep…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXAMETHASONE (Dexamethasone)
  • Floxuridine (floxuridine)
  • Gemcitabine (Gemcitabine)
  • OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Intrahepatic Cholangiocarcinoma | Phase 2 | Status: RECRUITING